Clinical Trial Update: Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction [Phase 1, Phase 2]

View source ↗

Summary

Feasibility study results for adjuvant S-1 therapy after R0 resection in stomach and esophagogastric junction adenocarcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Adenocarcinoma of the Stomach

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Adenocarcinoma,Stomach, Adenocarcinoma, Esophagogastric Junction | Phase 1, Phase 2 | Status: COMPLETED